| 48.25 BATS BZX Real-Time Price As of 10:46am ET |  +0.64 / +1.34%Today’s Change | 35.30 Today|||52-Week Range 49.22 | +27.04% Year-to-Date |
| Here’s Why FibroGen’s Stock Popped Friday Nov 11 / MotleyFool.com - Paid Partner Content |
| Previous close | 47.61 |
| Today’s open | 48.31 |
| Day’s range | 48.10 - 48.39 |
| Volume | 552,251 |
| Average volume (3 months) | 3,333,909 |
| Market cap | $124.6B |
| Earnings growth (last year) | -29.11% |
| Earnings growth (this year) | +3.40% |
| Earnings growth (next 5 years) | +18.25% |
| Revenue growth (last year) | -2.88% |
| P/E ratio | 60.1 |
| Price/Sales | 4.36 |
| Price/Book | 9.65 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.51 | -0.59% |
| SNYSanofi | -0.56 | -1.19% |
| BMYBristol-Myers Squibb | -0.14 | -0.25% |
| LLYEli Lilly and Co | +1.49 | +1.30% |
| Next reporting date | February 14, 2020 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $22.1B |
| Annual profit (last year) | $2.2B |
| Net profit margin | 9.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
